Jasper Therapeutics, Inc.
JSPR · NASDAQ
Bulios Fair Price
$0.49
14.1% downside
Trenutna cena
$0.57
Po podatkih Bulios Fair Price je delnica JSPR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Jasper Therapeutics, Inc. (JSPR) is a biotechnology company based in the USA that specializes in researching and developing novel therapeutic approaches in the field of hematopoiesis and cell therapy. The company focuses on treating hematological disorders and other diseases related to blood formation and the immune system. Their research centers on the use of stem cells and cell therapy to regenerate hematopoietic tissues and treat various diseases. Jasper Therapeutics aims to bring innovative and effective treatment methods that could revolutionize medical practices and improve the quality of life for patients. With the growing interest in the biotechnology industry, shares of Jasper Therapeutics, Inc. could present an intriguing investment opportunity for those who believe in the prospects of biotechnology and new therapeutic approaches.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Jeetinder Singh Mahal
Employees
22
Headquarters
Redwood City
Prihajajoči dogodki
Earnings
Upcoming earnings report